Products 147059-72-1
CAS 147059-72-1 appears in our catalog under these names: Trovafloxacin, Trovafloxacin, 95%, Trovafloxacin, >95% (HPLC), (1R,5R,6R)-7-(6-Amino-3-Azabicyclo(3.1.0)Hex-3- Yl)-1-(2,4-difluorophenyl)-6-Fluoro-1,4-dihydro-4-Oxo-1,8-naphthyridine-3-carbox, rel-7-((1R,5S,6s)-6-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, 99.21% ,, 99.21% ,. Offered by: GLPBio, Combi-blocks, TRC, Biosynth, Chemat. Available pack sizes: 1mg, 250mg, 10mg, 2,5mg, 25mg, 5mg, 50mg, 100mg.
Trovafloxacin is a 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 6-amino-3-azabicyclo[3.1.0]hex-3-yl substituents at positions 1, 6 and 7 respectively. A broad-spectrum antibiotic that was withdrawn from the market due to risk of liver failure. It has a role as an antimicrobial agent, an antibacterial drug, a hepatotoxic agent, a topoisomerase IV inhibitor and a DNA synthesis inhibitor. It is a monocarboxylic acid, an amino acid, an azabicycloalkane, a difluorobenzene, a primary amino compound, a tertiary amino compound, a 1,8-naphthyridine derivative, a quinolone antibiotic and a fluoroquinolone antibiotic. It is a conjugate base of a trovafloxacin(1+).
Source: ChEBI
| Molecular formula | C20H15F3N4O3 |
|---|---|
| Molecular weight | 416.4 g/mol |
| IUPAC name | 7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid |
| InChIKey | WVPSKSLAZQPAKQ-SOSAQKQKSA-N |
| SMILES | C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F |
Computed by PubChem (NCBI)